Purchase Order 75N91024P00177
Award Date
1/28/24
Potential Completion Date
1/27/25
Potential Value
$16K
Federal Agency
National Cancer Institute
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
811310 - Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Roche Diagnostics Corporation was awarded a firm fixed price purchase order by the National Cancer Institute, a component of the Department of Health and Human Services, with a potential value of $15,649.32. The agreement is for services to be performed at the agency's location in Rockville, Maryland, with a completion date of March 24, 2025. No set-aside designation was applied. This purchase order is likely placed against an existing Indefinite Delivery Contract or Blanket Purchase Agreement...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded Roche Diagnostics Corporation a one-year, firm fixed price purchase order valued at approximately $15,649 under a maintenance agreement. The contract calls for Roche to provide maintenance services in support of equipment located at the agency's facilities in Bethesda, Maryland. As the prime contractor, Roche will be responsible for ensuring the agency's diagnostic and laboratory equipment...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for a maintenance agreement. The contract has a ceiling value of $15,649.28 and a ultimate completion date of December 28, 2025. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
<p>Roche Diagnostics Corporation was awarded a $25,458.64 firm fixed price delivery order contract by the Department of Health and Human Services' National Institutes of Health National Cancer Institute for reagents and consumables. The contract has no set-aside designation and requires completion by June 9, 2023. Roche will provide the requested products to support the National Cancer Institute's biomedical research efforts from its place of performance in Castleton, Indiana.</p>
This is a $15,649.32 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The service agreement, which has no set-aside designation, covers the supply of laboratory instruments, reagents, test kits, and associated products and services through December 2025. Roche Diagnostics, a manufacturer of in vitro diagnostics, holds several Indefinite Delivery Vehicles and Blanket...
<p>Roche Diagnostics Corporation was awarded a $20,215.65 firm fixed price delivery order contract by the National Institutes of Health's National Cancer Institute to provide reagents and consumables. The contract has no set-aside designation and runs through October 24, 2022. As the prime contractor, Roche Diagnostics will supply the requested products to support the National Cancer Institute's biomedical research efforts from its place of performance in Castleton, Indiana.</p>
Roche Diagnostics Corporation was awarded a $24,366.62 firm fixed price delivery order for reagents and consumables by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute. The contract has no set-aside designation and requires performance in Castleton, Indiana, with completion by April 23, 2024. As the prime contractor, Roche Diagnostics will provide laboratory materials to support the National Cancer Institute's biomedical research efforts...
<p>Roche Diagnostics Corporation was awarded a $62,593.75 firm fixed price delivery order contract by the National Institutes of Health's National Cancer Institute to provide reagents and consumables. The contract has no set-aside designation and runs through April 16, 2021. As the prime contractor, Roche Diagnostics will supply the requested products to support the National Cancer Institute's biomedical research efforts.</p>
Roche Diagnostics Corporation was awarded a $30,375.00 firm-fixed-price purchase order contract by the Department of Health and Human Services National Institutes of Health Clinical Center to provide a Roche Cobas z480 maintenance agreement for a base year plus four option years. The contract is not set-aside and was awarded through simplified acquisition procedures without full and open competition. Roche Diagnostics is the original equipment manufacturer of the Cobas z480 analyzer, which is...
Roche Diagnostics Corporation has been awarded a $16,756.40 firm fixed price delivery order against an unspecified government-wide acquisition contract by the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health, to provide reagents and consumables. The contract has a period of performance from October 18, 2023 through November 17, 2023. Place of performance will be Roche's facility located in Castleton, Indiana. No set aside...